RA16-Modified DNA Tetrahedra: Targeted Delivery and Inhibition in Non-Small Cell Lung Cancer
ACS Applied Bio Materials · 2025
DOI: 10.1021/acsabm.5c00013 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Bio Materials, 2025. Verfasst von Kunyao Xu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Beijing University of Chemical Technology, Beijing 100029, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Aptamers, Nucleotide, DNA. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: National Postdoctoral Program for Innovative Talents, China Postdoctoral Science Foundation, State New Drug Research and Development.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Beijing University of Chemical Technology, Beijing 100029, China.
- Biopharmaceutical R&D Center, Chinese Academy of Medical Sciences & Peking Union Medical College, Suzhou 215126, Jiangsu, China.
- Biopharmagen Corp, Suzhou 215126, Jiangsu, China.
ORCID-Profile: Hanlu Wang
Förderung
- National Postdoctoral Program for Innovative Talents
- China Postdoctoral Science Foundation
- State New Drug Research and Development
Zitieren
APA
Xu, K., Wang, H., Jiang, Y., & Wang, H. (2025). RA16-Modified DNA Tetrahedra: Targeted Delivery and Inhibition in Non-Small Cell Lung Cancer. ACS Applied Bio Materials. https://doi.org/10.1021/acsabm.5c00013
Vancouver
Xu K, Wang H, Jiang Y, Wang H. RA16-Modified DNA Tetrahedra: Targeted Delivery and Inhibition in Non-Small Cell Lung Cancer. ACS Applied Bio Materials. 2025. doi:10.1021/acsabm.5c00013
BibTeX
@article{Xu2025,
author = {Xu, Kunyao and Wang, Hao and Jiang, Yongping and Wang, Hanlu},
title = {RA16-Modified DNA Tetrahedra: Targeted Delivery and Inhibition in Non-Small Cell Lung Cancer},
journal = {ACS Applied Bio Materials},
year = {2025},
doi = {10.1021/acsabm.5c00013}
}
EUVIMED